01/30/2026 | Press release | Archived content
Tags:
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)-Caremark Rx, Express Scripts (ESI), and OptumRx-and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
PUBLIC STATEMENT: Statement of Chairman Andrew N. Ferguson Regarding PBMs